The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this method offers a less invasive way to deliver https://sabrinaltdy078572.qowap.com/99998051/glp-1-patches-a-novel-approach-to-diabetes-control